ADARx Pharmaceuticals, Inc. (ADRX): SCHEDULE 13D filed Oct 2, 2026

Form type

SCHEDULE 13D

Filing date

Oct 2, 2026

Accession number

0000947871-26-000917

Filer

ADARx Pharmaceuticals, Inc. (CIK 1802369)